Tag: Cancer: Lung
Residential Segregation May Worsen NSCLC Outcomes for Black Patients
Blacks more likely to present at advanced stage, less likely to receive surgery, have higher mortality at higher residential segregation levels
Disparities in Lung Cancer Screening Eligibility Still Exist
Findings seen despite the U.S. Preventive Services Task Force revised eligibility criteria
Pandemic Has Disrupted Lung Cancer Screenings
Once operations resumed, decrease seen in new patients screened, proportion of suspicious nodules increased
Tagrisso Approved as Adjuvant Therapy for NSCLC With EGFR Mutations
Current approval of the once-daily tablet indicated for patients who have undergone complete tumor removal
Immune Checkpoint Inhibitor Therapy Tied to Cardiac Event Risk
Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i
Oral Microbiome Tied to Lung Cancer Risk in Never-Smokers
Risk varies according to profile of the oral microbiota; risk lower with greater abundance of Spirochaetia, Bacteroidetes
Genetic Ancestry Tied to Lung Cancer Mutations in Latin Americans
Mutation frequencies of EGFR and KRAS were 30 and 10 percent, respectively, and 23 and 13 percent, respectively, for Mexican and Colombian patients
Women Have Lower Risk for Death After Resection for Lung Cancer
Restricted mean survival time difference was 0.84 years at 10 years for women undergoing pulmonary resection
ALA: Lung Cancer Survival Has Increased Nationally to 22.6 Percent
People of color face worse outcomes, have lower likelihood of being diagnosed early, receiving surgery
Less Than One in 20 Eligible Adults Receives Lung Cancer Screening
Lung cancer screening at the state level does not correlate with lung cancer burden
